[1] CUBUK, M O,UNSAL E.Anatomic and functional results of idiopathic macular epiretinal membrane surgery[J].Int J Ophthalmol,2020,13(4):614-619.
[2] AKıNCıOLU D, ÖZGE G, KÜÇÜKEVCILIOLU M,et al. Surgical outcomes of idiopathic epiretinal membrane: the Gulhane experience[J].Turk J Ophthalmol,2018,48(2): 75-80.
[3] CHEN H,CHI W,CAI X J,et al.Macular microvasculature features before and after vitrectomy in idiopathic macular epiretinal membrane: an OCT angiography analysis[J]. Eye, 2019,33(4):619-628.
[4] BU S C,KUIJER ROEL,LI X R,et al.Idiopathic epiretinal membrane[J]. Retina, 2014,34(12): 2317-2335.
[5] SCHECHET S A,DEVIENCE E,THOMPSON J T, The effect of internal limiting membrane peeling on idiopathic epiretinal membrane surgery, with a review of the literature[J]. Retina, 2017,37(5): 873-880.
[6] GHANEM A A, ARAFA L F, LEWA A M.Tumor necrosis factor-α and interleukin-6 levels in patients with primary open-angle glaucoma[J].J Clin Exp Ophthalmol,2011,2(1):1-5.
[7] ZHAO M,ZHANG C,CHEN X M,et al.Comparison of intravitreal injection of conbercept and triamcinolone acetonide for macular edema secondary to branch retinal vein occlusion[J].Int J Ophthalmol, 2020,13(11):1765-1772.
[8] CHEN J,DU L,LONG T, et al. Application and research progress of active stain in vitreoretinal surgery[J].J Clin Ophthalmol,2017,25(3):284-287.
[9] 骆贵军,姚莎莎.玻璃体切割联合黄斑前膜撕除对特发性黄斑前膜患者视力和视物变形的影响[J].国际眼科杂志,2019,19(2):264-267.
[10] 刘巨平,邵彦,李筱荣.27G+经结膜免缝合玻璃体切除术在玻璃体视网膜疾病中应用的临床观察[J].中华眼科杂志,2018,54(12):918-922.
[11] PARK D W,DUCELP U, GARDA J,et al.Macular pucker removal with and without intera limiting membrane peeling : pilot study[J].Ophthalmol,2003,1100(1):62-64.
[12] 王贝贝,李秋明,董淑倩,等.玻璃体切除后黄斑水肿的治疗[J].国际眼科纵览,2019,43(6):366-372.
[13] BEER P M, BAKRI S J, SINGH R J, et al. Intraocular concentrationand pharmacokinetics of triamcinolone acetonide after a single intravitreal injection[J].Ophthalmol,2003,110(4):681-686.
[14] CHIN H S, PARK T S, MOON Y S, et al. Difference in clearance ofintravitreal triamcinolone acetonide between vitrectomized andnonvitrectomized eyes[J].Retina,2005,25(5):556-560.
[15] TUUMINEN R,LOUKOVAARA S.Statin medication in patients with epiretinal membrane is associated whith low intravitreal EPO,TGF-beta-1,and VEGF levels[J].Clin Ophthalmol,2016(10):921-928.
[16] TF A,VRJA B,RJHD E, et al. Aqueous humor cytokines and long-term response to anti-vascular endothelial growth factor therapy in diabetic macular edema[J].Am J Ophthalmol, 2019(206): 176-183.
[17] AKıNCıOLU D, ÖZGE G, KÜÇÜKEVCILIOLU M. Aqueous humor cytokines in patients with acute nonarteritic anterior ischemic optic neuropathy[J]. Am J Ophthalmol, 2017 (178): 188-189.
[18] MODI A A,SHARMA K,SUDHAKAR N P, et al. Aqueous humor cytokines and therapeutic customization in nonresponding macular edema secondary to retinal vein occlusion[J]. Retinal Cases Brief Rep, 2021, 15(2): 127-130.
[19] LUO, Y, ZHENG S G. Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms[J]. Front Immunol, 2016 (7): 604.
[20] BIANCON I V, SAHEBKAR A, ATKIN S L, et al.The regulation and importance ofmonocyte chemoattractant protein-1[J].Curr Opin Hematol, 2018, 25(1) :44-51. |
